SAB Biotherapeutics (SABS) Share-based Compensation (2021 - 2026)
SAB Biotherapeutics (SABS) reported Share-based Compensation of $7.25 million for Q2 2026, compared with $627,049 a year earlier and up 32.7% from the prior quarter.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Share-based Compensation (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, SAB Biotherapeutics' Share-based Compensation came in at $16.68 million, up 462.9% year-over-year; for FY2025, it came in at $5.21 million, up 77.1% from FY2024.
- Share-based Compensation has a five-year compound annual growth rate of 32.1% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $2.94 million in FY2024 (-24.2%), $3.88 million in FY2023 (+45.1%), $2.67 million in FY2022 (+15.5%) and $2.31 million in FY2021 (+78.7%).
- The Q2 2026 figure ranks as the highest quarterly Share-based Compensation in data going back to Q1 2021.
- Year over year, Share-based Compensation gained in four of the last seven quarters, with growth averaging 162.7%.
- The high point for year-over-year Share-based Compensation in five years was Q1 2026 (growth of 790.8%); the low point was Q4 2024 (a decline of 66.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $5.46 million (Q1 2026), $3.17 million (Q4 2025) and $800,913 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | SAB Biotherapeutics | 268.01 Mn | 268.01 Mn | - | 7.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.25 Mn |
| Mar 31, 2026 | 5.46 Mn |
| Dec 31, 2025 | 3.17 Mn |
| Sep 30, 2025 | 800,913.00 |
| Jun 30, 2025 | 627,049.00 |
| Mar 31, 2025 | 612,951.00 |
| Dec 31, 2024 | 674,135.00 |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 601,433.00 |
| Mar 31, 2024 | 617,445.00 |
| Dec 31, 2023 | 1.99 Mn |
| Sep 30, 2023 | 639,246.00 |
| Jun 30, 2023 | 644,815.00 |
| Mar 31, 2023 | 602,780.00 |
| Dec 31, 2022 | 628,539.00 |
| Sep 30, 2022 | 578,203.00 |
| Jun 30, 2022 | 569,861.00 |
| Mar 31, 2022 | 897,600.00 |
| Dec 31, 2021 | 651,472.00 |
| Sep 30, 2021 | 880,664.00 |
API Access
SAB Biotherapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();